PROCEPT BioRobotics Corporation (PRCT) vs VAREX IMAGING (VREX)

PROCEPT BioRobotics Corporation and VAREX IMAGING are both Medical Devices companies. PROCEPT BioRobotics Corporation is the larger, with a market value of $1.0B against $784.3M — 1.3× the size. PROCEPT BioRobotics Corporation has negative trailing earnings, so its P/E is not meaningful; VAREX IMAGING trades at 34.8×. PROCEPT BioRobotics Corporation grew revenue faster over the last twelve months: 22.7% against 5.31%. VAREX IMAGING has the higher net margin (2.55% vs −32.5%) and the higher return on invested capital (5.95% vs −43.6%). Across the 18 metrics below, VAREX IMAGING leads on 12 and PROCEPT BioRobotics Corporation on 6.

Valuation

Metric PRCT VREX Medical Devices median
P/E n/m 34.81 22.18
P/S 2.91 0.90 2.70
P/B 2.89 1.52 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m 10.15 11.78
EV/Sales 2.39 1.18 2.38
Earnings yield (11.28%) 2.87% (8.22%)
Free cash flow yield (8.65%) (2.60%) (7.80%)

Profitability

Metric PRCT VREX Medical Devices median
Gross margin 64.22% 34.32% 56.01%
Operating margin (33.86%) 8.35% (15.03%)
Net margin (32.54%) 2.55% (20.40%)
Free cash flow margin (25.17%) (2.34%) (7.24%)
Return on equity (30.24%) 4.51% (15.32%)
Return on assets (22.12%) 2.03% (19.72%)
Return on invested capital (43.57%) 5.95% (10.33%)

Growth

Metric PRCT VREX Medical Devices median
Revenue growth (TTM) 22.69% 5.31% 8.80%
EPS growth (last fiscal year) 1.71% (45.30%) —
Revenue growth, 5-year CAGR 109.04% 2.73% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PRCT VREX Medical Devices median
Debt to equity 0.15 0.68 0.07
Current ratio 6.55 3.38 2.50
Net debt to EBITDA 2.41 2.21 0.49

Dividend

Metric PRCT VREX Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric PRCT VREX Medical Devices median
Market cap 1.01b 784.30m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack